Literature DB >> 15615648

Pinning down phosphorylated tau and tauopathies.

Jormay Lim1, Kun Ping Lu.   

Abstract

Neurofibrillary tangles (NFTs) are prominent neuronal lesions in a large subset of neurodegenerative diseases, including Alzheimer's disease (AD). NFTs are mainly composed of insoluble Tau that is hyperphosphorylated on many serine or threonine residues preceding proline (pSer/Thr-Pro). Tau hyperphosphorylation abolishes its biological function to bind microtubules and promotes microtubule assembly and precedes neurodegeneration. Not much is known about how tau is further regulated following phosphorylation. Notably, we have recently shown that phosphorylated Ser/Thr-Pro motifs exist in two distinct conformations. The conversion between two conformations in some proteins is catalyzed by the prolyl isomerase Pin1. Pin1 binds to tau phosphorylated specifically on the Thr231-Pro site and probably catalyzes cis/trans isomerization of pSer/Thr-Pro motif(s), thereby inducing conformational changes in tau. Such conformational changes can directly restore the ability of phosphorylated Tau to bind microtubules and promote microtubule assembly and/or facilitate tau dephosphorylation by its phosphatase PP2A, as PP2A activity is conformation-specific. Furthermore, Pin1 expression inversely correlates with the predicted neuronal vulnerability in normally aged brain and also with actual neurofibrillary degeneration in AD brain. Moreover, deletion of the gene encoding Pin1 in mice causes progressive age-dependent neuropathy characterized by motor and behavioral deficits, tau hyperphosphorylation, tau filament formation and neuronal degeneration. Distinct from all other mouse models where transgenic overexpression of specific proteins elicits tau-related pathologies, Pin1 is the first protein whose depletion causes age-dependent neurodegeneration and tau pathologies. Thus, Pin1 is pivotal in maintaining normal neuronal function and preventing age-dependent neurodegeneration. This could represent a promising interventive target to prevent neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15615648     DOI: 10.1016/j.bbadis.2004.10.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  24 in total

1.  A PIN1 polymorphism that prevents its suppression by AP4 associates with delayed onset of Alzheimer's disease.

Authors:  Suk Ling Ma; Nelson Leung Sang Tang; Cindy Woon Chi Tam; Victor Wing Cheong Lui; Linda Chiu Wa Lam; Helen Fung Kum Chiu; Jane Ann Driver; Lucia Pastorino; Kun Ping Lu
Journal:  Neurobiol Aging       Date:  2010-06-30       Impact factor: 4.673

2.  Post-phosphorylation prolyl isomerisation of gephyrin represents a mechanism to modulate glycine receptors function.

Authors:  M Moretto Zita; Ivan Marchionni; Elisa Bottos; Massimo Righi; Giannino Del Sal; Enrico Cherubini; Paola Zacchi
Journal:  EMBO J       Date:  2007-03-08       Impact factor: 11.598

3.  Combinatorial Tau pseudophosphorylation: markedly different regulatory effects on microtubule assembly and dynamic instability than the sum of the individual parts.

Authors:  Erkan Kiris; Donovan Ventimiglia; Mehmet E Sargin; Michelle R Gaylord; Alphan Altinok; Kenneth Rose; B S Manjunath; Mary Ann Jordan; Leslie Wilson; Stuart C Feinstein
Journal:  J Biol Chem       Date:  2011-02-02       Impact factor: 5.157

Review 4.  Connecting cell-cycle activation to neurodegeneration in Drosophila.

Authors:  Vikram Khurana; Mel B Feany
Journal:  Biochim Biophys Acta       Date:  2006-10-18

5.  Molecular basis for an ancient partnership between prolyl isomerase Pin1 and phosphatase inhibitor-2.

Authors:  Furqan Sami; Caroline Smet-Nocca; Meera Khan; Isabelle Landrieu; Guy Lippens; David L Brautigan
Journal:  Biochemistry       Date:  2011-07-08       Impact factor: 3.162

6.  The prolyl isomerase Pin1 is overexpressed in human esophageal cancer.

Authors:  Huawei Jin; Jie Jiang; Lifang Sun; Fangfang Zheng; Chengyan Wu; Lin Peng; Yufen Zhao; Xueji Wu
Journal:  Oncol Lett       Date:  2011-08-23       Impact factor: 2.967

7.  Proteomic analysis of protein phosphorylation and ubiquitination in Alzheimer's disease.

Authors:  Stefani N Thomas; Diane Cripps; Austin J Yang
Journal:  Methods Mol Biol       Date:  2009

8.  Pin1-mediated Modification Prolongs the Nuclear Retention of β-Catenin in Wnt3a-induced Osteoblast Differentiation.

Authors:  Hye-Rim Shin; Rabia Islam; Won-Joon Yoon; Taegyung Lee; Young-Dan Cho; Han-sol Bae; Bong-Su Kim; Kyung-Mi Woo; Jeong-Hwa Baek; Hyun-Mo Ryoo
Journal:  J Biol Chem       Date:  2016-01-06       Impact factor: 5.157

9.  AtCyp59 is a multidomain cyclophilin from Arabidopsis thaliana that interacts with SR proteins and the C-terminal domain of the RNA polymerase II.

Authors:  Monika Gullerova; Andrea Barta; Zdravko J Lorkovic
Journal:  RNA       Date:  2006-02-22       Impact factor: 4.942

Review 10.  New age of neuroproteomics in Alzheimer's disease research.

Authors:  Branislav Kovacech; Norbert Zilka; Michal Novak
Journal:  Cell Mol Neurobiol       Date:  2009-02-19       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.